Presentation is up on the small-mid conference. Nothing too much to add from the last one but the MCI planning is complete and they will announce the parameters of the study fairly soon. Still a lot of excitement and mystery from the 4th trial they want to run and they claim the feasibility is "advanced". The only reason they haven't announced it would be because there is a 3rd party involved in the development/funding, hopefully.
Trial start date still ambiguous.
emphasis on conservative figures yielding greater than $14 billion US per year for MCI alone.
Bill continues to insinuate an overlap between MCI and XanaHES.
could see .04, page-160
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $76.57M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 521506 | 2.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.5¢ | 289433 | 2 |
View Market Depth
| Last trade - 09.06am 02/10/2024 (20 minute delay) ? |
| ACW (ASX) Chart |
Day chart unavailable